CD274 and neoplasm: PD-L1, an immune-negative molecule, is highly expressed on the surface of tumor cells [11, 12] and binds with PD-1 on T cells, resulting in the inhibition of T cell-mediated killing of tumor cells [13] and promoting tumor progression [14].